Tag Archives: ERJ

Top Blue Chip Stocks To Own Right Now

This is part of a series of stories that comprise TheStreet’s Blue Chip Studio, which will illuminate issues related to corporate board performance, activism, dealmakers and personalities revealed by analysis of data generated by BoardEx, a business unit of TheStreet.

BlackRock (BLK), the world’s largest asset manager, said it will be putting pressure on companies to address boardroom diversity as part of a series of initiatives for 2017-2018 that the company’s 30-member Investment Stewardship team will discuss with portfolio companies.

The New York-based firm, with $5.1 trillion under management, said board composition, effectiveness, and accountability remain a top priority, and that it plans to engage companies in a constructive manner.

“More specifically, over the coming year, we will engage companies to better understand their progress on improving gender balance in the boardroom,” the firm said on its website on Monday. “Diverse boards, including but not limited to diversity of expertise, experience, age, race and gender, make better decisions.”

Top Blue Chip Stocks To Own Right Now: Lexaria Bioscience (LXRP)

Advisors’ Opinion:

  • [By Matthew Briar]

    What do you get when you cross a science that drastically improves the absorption of cannabidiol (the healthy component of cannabis) with pterostilbene (an antioxidant) tablet? It’s not a joke in search of a punch line. It’s going to be the health supplement millions of consumers have been waiting for, brought to them by a joint venture between NeutriSci International Inc (CVE:NU) and Lexaria Bioscience Corp (OTCMKTS:LXRP). The two companies announced this morning they were entering a joint venture that would utilize Lexaria Bioscience’s proprietary infusion platform and tap into NeutriSci International’s existing distribution network to create and market a whole new supplement product line.

    Lexaria has developed and patented a technology that makes valuable molecules taste better and absorb better in the digestive tract. This platform could be applied to a variety of nutritional and health-oriented favorites, but Lexaria is starting with hemp as it’s the most underserved market and arguably the biggest growth opportunity.

    Just to be clear, hemp and marijuana are not the same thing. Hemp doesn’t have any tetrahydrocannabinol (or THC) in it, which is the key driver of its psychoactive — the ‘high’ — response. Hemp, and hemp oil to be exact, does have cannabidiol in it though, and for those who’ve been following the saga of medical marijuana and cannabis, they’ll know cannabidiol can provide a lot of various medical benefits like the reduction of nausea, control of seizures, anti-cancer activity, anti-inflammation effects, and more.

    NeutriSci International is Canadian corporation that specializes in the marketing, development and distribution of proprietary nutraceuticals. It’s got a rather wide array of products in its portfolio, but the one of immediate interest is its pterostilbene, as it fits best with the hemp-absorption technology Lexaria Bioscience brings to the table.

    Pterostilbene (found in blueberries, by the way) is o

  • [By Matthew Briar]

    Granted, it’s not always a fully-appreciated distinction. Even though the federal government accurately recognizes that hemp and marijuana are only variants of the same species, Cannabis sativa, the DEAdoesn’t necessarily enforce its drug laws as such. For legitimate medical purposes, the government is perfectly willing to leave the matter alone.

    The good news is, governments – federal as well as state – are finally starting to figure out the distinct differences between marijuana and hemp, and that bodes well for a young and hungry startup called Lexaria Bioscience Corp (OTCMKTS:LXRP).

  • [By Matthew Briar]

    Last week — to the day, in fact — Lexaria Bioscience Corp (OTCMKTS:LXRP) announced it was teaming up with neutraceutical company NeutriSci International Inc (CVE:NU) to create a new kind of health supplement that gave consumers the ability to tap into the benefits of hemp. We hailed it as the shape of things to come. What we didn’t know, however, was how quickly those things would take shape. Just this morning the company told LXRP shareholders it was already forging another such symbiotic relationship…. this one with Hempco Food and Fiber Inc (CVE:HEMP).

    Simply put, Lexaria Bioscience is focused on improving the bioavailability of the healthy stuff found in food, supplements, vitamins, and yes, even in cannabis and hemp.

    It’s not widely recognized, but the bulk of the vitamins, anti-oxidants, minerals, amino acids and all the other desirable components of the pills you take and foods you eat don’t actually get absorbed into your body. Sometimes as much as 96% of the ingredient in question isn’t extracted, and instead passes right through. Not only is it a waste of time and money, it’s a bit of a hassle to swallow a big capsule — or several capsules — for little to no benefit.

    Lexaria Bioscience changes this. In short, Lexaria has developed and patented a proprietary technology that makes valuable molecules taste better and absorb better in the digestive tract. This platform could be applied to a variety of nutritional and health-oriented favorites, but Lexaria is starting with hemp as it’s the most underserved market and arguably the biggest growth opportunity. Hemp, and hemp oil to be exact, can provide a lot of various medical benefits like the reduction of nausea, control of seizures, anti-cancer activity, anti-inflammation effects, and more.

    The future for Lexaria Bioscience is partnerships… licensing its science and know-how to companies with existing product lines and distribution networks that can easily inject hemp

  • [By Bryan Murphy]

    When you’ve come up with a technology that increases the digestion of minerals, vitamins, compounds, nutrients, and even medicine, the first thing you want to do is protect that idea so nobody else can commercialize it except you. Well, Lexaria Bioscience Corp (OTCMKTS:LXRP) has figured out how to do the former, and it’s been doing the latter… in spades. First it started by building a wall around its platform in the United States, but as of today’s press release is building a wall internationally as well.

    It’s an exciting prospect to be sure. In simplest terms, Lexaria Bioscience is focused on improving the bioavailability of the healthy stuff found in food, supplements, vitamins, and yes, even in cannabis and hemp.

    It’s largely unrecognized, but the bulk of the vitamins, anti-oxidants, minerals, amino acids and all the other desirable components of the pills you take and foods you eat don’t actually get absorbed into your body. Sometimes as much as 96% of the ingredient in question isn’t extracted, and instead passes right through. Not only is it a waste of time and money, it’s a bit of a hassle to swallow a big capsule — or several capsules — for little to no benefit.

    Lexaria Bioscience changes the game, so to speak. How? A proprietary process that makes valuable molecules taste better and absorb better in the digestive tract. This platform could be applied to a variety of nutritional and health-oriented favorites, but Lexaria is starting with hemp as it’s the most underserved market and arguably the biggest growth opportunity.

    The science: Lexaria Bioscience has defined a way to combine cannabinoids with lipids — or fatty acids — at the molecular level. It matters, because the human endocannabinoid system is itself lipid based, making this format the easiest and most effective means of introducing the medicinal and health benefits of hemp and hemp oil.

    And the results have been impressive in two different studies

  • [By Jim Robertson]

    In October, small cap food sciences stockLexaria Bioscience Corp (OTCQB: LXRP) was issuedU.S. Patent No. 9,474,725 Cannabinoid Infused Food and Beverage Compositions and Methods of Use Thereof and now the company is seeking to expand this patent internationally. This patent protects Lexaria Bioscience Corps intellectual property related to infusion of cannabinoid compounds in edible products and includes a set of claims that describe the Companys method of combining a fatty acid compound with any non-psychoactive cannabinoid for improved bioavailability and taste performance in both food and beverage formats.

  • [By Bryan Murphy]

    Though they’re not the same thing, anything that’s good for marijuana is good for hemp. That’s why when eight out of nine states that had marijuana on the ballot two Tuesday’s ago approved those measures, things got a lot more compelling for owner of Lexaria Bioscience Corp (OTCMKTS:LXRP).

    What’s the difference? Hemp a strains of Cannabis sativa that have been bred specifically for fiber used for clothing, construction, oils and topical ointments, nutritional benefits and a wide array of other purposes that don’t involve getting “high.” Marijuana is a slang term used to describe strains of Cannabis sativa that are bred for the potent resinous glands, or trichomes, that grow on the flowers and some leaves… the strain packed with tetrahydrocannabinol (or THC).

    They would be easy to confuse, and commonly are. The potential for confusion, in fact, is the chief reason government agencies have been hesitant to support one and ban the other. With marijuana now legalized for use for one reason or another in more than half the United States though, knowledge and understanding of the difference will soon follow.

    Great, but what’s that got to do with Lexaria Bioscience is on the leading edge of the movement of heightened understanding of what hemp is, and what it does.

    The medical benefits of the non-psychoactive form of Cannabis sativa are impressive to say the least. Among other benefits, hempseed oil has also shown a positive effect on dermatological diseases and lipid metabolism (the process by which fatty acids are broken down in the body). Hempseed also has high levels of vitamins A, C and E and ?-carotene, and it is rich in minerals like phosphorus, potassium, magnesium, sulfur and calcium. As a food, hempseed oil is nutritious – it contains an excellent balance of polyunsaturated fatty acids – and it reportedly tastes good, too.

    Problem: Hemp isn’t effectively absorbed into the body, and as such, it’s difficult to make effec

Top Blue Chip Stocks To Own Right Now: Dow Treasuries(DV)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart of Apollo Education Group along with peersITT Educational Services, Inc (NYSE: ESI) and DeVry Education Group Inc (NYSE: DV) reflect the headwinds from the Obama administration:

Top Blue Chip Stocks To Own Right Now: Check Point Software Technologies Ltd.(CHKP)

Advisors’ Opinion:

  • [By Jayson Derrick]

    It is unclear which company or companies will benefit from this executive order. But that isn’t stopping investors from placing their bets as most cybersecurity stocks were trading higher during Friday’s trading session; at the same time, the Dow Jones Industrial Average and S&P 500 index were trading in the red.

    Shares of Barracuda Networks Inc (NYSE: CUDA) were trading higher by 2.98 percent at $21.77. Shares of Check Point Software Technologies Ltd. (NASDAQ: CHKP) were trading higher by 1.21 percent at $107.00. Shares of FireEye Inc (NASDAQ: FEYE) were trading higher by 0.70 percent at $14.55. Shares of Palo Alto Networks Inc (NYSE: PANW) were trading higher by 0.62 percent at $115.86.

    Related Links:

  • [By WWW.THESTREET.COM]

    Turning Around Cybersecurity Through Activism
    As competition climbs and spending slows, security has attracted activists. (FEYE) (IMPV) (FTNT) (CHKP) Full story

  • [By Harsh Chauhan]

    But is it a good idea to buy FireEye based on this one incident, despite its huge losses, or should investors look at Check Point Software Technologies(NASDAQ:CHKP), given its focus on growing its bottom line? Let’s find out.

Top Blue Chip Stocks To Own Right Now: Embraer-Empresa Brasileira de Aeronautica(ERJ)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Friday, industrials shares fell by 0.12 percent. Meanwhile, top losers in the sector included Stericycle Inc (NASDAQ: SRCL), down 17 percent, and Embraer SA (ADR) (NYSE: ERJ), down 13 percent.

  • [By Paul Ausick]

    Boeing also confirmed on Thursday that it has discussed a “possible combination” with Brazil’s Embraer S.A. (NYSE: ERJ), a response to the deal Bombardier struck with Airbus in which the European company took control of Bombardier’s C Series program. A deal between Boeing and Embraer is no sure thing, mainly because the Brazilian government holds a controlling interest in Embraer.

Top Blue Chip Stocks To Own Right Now: SPDR S&P Bank ETF (KBE)

Advisors’ Opinion:

  • [By ]

    Shares of banks have underperformed this year on a narrow net interest margin, the difference between long-term and short-term rates, and continued regulatory costs from post-crisis legislation. The SPDR S&P Bank ETF (NYSE: KBE) has returned just 3.3% this year versus a 15% increase in the broader S&P 500 index.

  • [By Ben Levisohn]

    The market clearly likes the rate hike today. The S&P 500 has gained 1% to2,388.03 at 3:01 p.m. today. The Financial Select Sector SPDR ETF (XLF) has is little changed at $24.78, while the SPDR S&P Bank ETF (KBE) has dropped 0.7% to $44.59.

  • [By Ben Levisohn]

    Heck, it might just be easier to buy the lot, especially if you think earnings will be awesome. There’s an ETF for that you know (the SPDR S&P Bank ETF (KBE))?

Top Blue Chip Stocks To Own Right Now: UNIVERSAL INSURANCE HOLDINGS INC(UVE)

Advisors’ Opinion:

  • [By Jim Robertson]

    Small cap Florida insurance stock Universal Insurance Holdings (NYSE: UVE) has taken a hit with shares downalmost 17%over the past week on predictions that Hurricane Irma would hit Florida albeit sharesrose 8.51%on Friday when it became clear that it would not be as catastrophic as feared:

top 50 stocks to buy

U.K. stocks swung between small gains and losses on Thursday, but stayed close to a record high as miners continued to march higher on the back of a rally in commodity prices.

What are markets doing: The FTSE 100 index
UKX, +0.10%
was marginally higher at 7,622.45, building on a 0.4% gain from Wednesday that was enough for the benchmark to score an all-time closing high.

top 50 stocks to buy: Embraer-Empresa Brasileira de Aeronautica(ERJ)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Friday, industrials shares fell by 0.12 percent. Meanwhile, top losers in the sector included Stericycle Inc (NASDAQ: SRCL), down 17 percent, and Embraer SA (ADR) (NYSE: ERJ), down 13 percent.

  • [By Paul Ausick]

    Boeing also confirmed on Thursday that it has discussed a “possible combination” with Brazil’s Embraer S.A. (NYSE: ERJ), a response to the deal Bombardier struck with Airbus in which the European company took control of Bombardier’s C Series program. A deal between Boeing and Embraer is no sure thing, mainly because the Brazilian government holds a controlling interest in Embraer.

top 50 stocks to buy: Gartner, Inc.(IT)

Advisors’ Opinion:

  • [By Lisa Levin]

    CEB Inc. (NYSE: CEB) shares were also up, gaining 21 percent to $74.90 after Gartner Inc (NYSE: IT) announced plans to acquire the company for $2.6 billion in cash and stock.

top 50 stocks to buy: Norsat International Inc.(NSAT)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Norsat International Inc (USA) (NYSE: NSAT) got a boost, shooting up 22 percent to $9.85 after the company reported the receipt of new indication of interest by Privet Fund Management LLP at $10.25 per share.

top 50 stocks to buy: Cummins Inc.(CMI)

Advisors’ Opinion:

  • [By Reuben Gregg Brewer]

    Making mining equipment has been a horrible business over the last few years. The industry has been hard-hit by the spending cutbacks at mine sites around the world. For example, BHP Billiton Limited trimmed its capital exploration expenditures by roughly 70% between fiscal 2013 and 2016. No wonder Caterpillar Inc. (NYSE:CAT), Komatsu Ltd. (NASDAQOTH:KMTUY), and Cummins Inc. (NYSE:CMI) have been hurting. Only that looks like it’s starting to change, which means this trio could be at the top of a list of mining equipment companies to buy in 2017.

  • [By Reuben Gregg Brewer]

    Ever walk past a construction site? It’s hard not to be enthralled by all the heavy construction machinery moving things around. With the world’s developing economies still building at a relatively fast pace and developing economies, like the United States, in desperate need of upgrading their aging infrastructure, the companies behind that construction machinery could be just as exciting as a construction site in the years ahead. Which is why Caterpillar Inc. (NYSE:CAT), Cummins Inc. (NYSE:CMI), and Terex Corporation (NYSE:TEX) are three of the top construction machinery stocks to look at right now.

  • [By WWW.THESTREET.COM]

    In the Lightning Round, Cramer was bullish on Salesforce.com (CRM) , Paccar (PCAR) , Cummins (CMI) , ConocoPhillips (COP) , Adobe Systems (ADBE) , Annaly Capital (NLY) and Hewlett Packard Enterprise (HPE) .

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close Friday was Cummins Inc. (NYSE: CMI) which traded down about 5% at $159.44. The stocks 52-week range is $134.06 to $181.79. Volume was over 3.5 million versus the daily average of 1.2 million shares.

  • [By WWW.THESTREET.COM]

    There are lots of stories like that out there these days. People were perplexed about the Illinois Tool Works (ITW) and Cummins Engine (CMI) and Caterpillar (CAT) quarters, but they turned out to be classic buying opportunities after years of being sell opportunities if the stocks had run. I can’t explain to you how amazing that is. Here are three stocks that have spent months and months in purgatory when they have missed or guided down or slashed forecasts. Now they are up gigantically.

top 50 stocks to buy: SPDR Blmbg Barclays Em Mkts Lcl Bd ETF (EBND)

Advisors’ Opinion:

  • [By Todd Shriber, ETF Professor]

    DWFI also holds the SPDR Barclays Emerging Markets Local Bond ETF (NYSE: EBND), SPDR Barclays International Treasury Bond ETF (NYSE: BWX) and the SPDR Barclays Intermediate Term Corporate Bond ETF (NYSE: ITR).

Boeing Will Close 2017 as Top DJIA Stock

Boeing Co.’s (NYSE: BA) share price added less than half a point last week but it was not for lack of good news. With just a week to go in 2017, the aerospace giant is a sure thing to close out the year as the best performing stock among the 30 stocks that make up the Dow Jones Industrial Average (DJIA). Shares gained $1.76 last week to boost the year-to-date gain to nearly 90%.

Of the three other Dow stocks closest to Boeing’s yearly gain, Caterpillar Inc. (NYSE: CAT) rose by about 6.2% to a gain of nearly 68% for the year, Apple Inc. (NASDAQ: AAPL) added about 0.6% to close the week up just over 51% for the year to date, and Visa Inc. (NYSE: V) dropped about 1% to lower its annual gain to just over 44%.

Boeing’s week began with a final determination from the U.S. Department of Commerce on Boeing’s complaint against Canadian aircraft maker Bombardier for dumping the company’s CS-100 at below cost in the United States. The agency reiterated its 300% duty on imported Bombardier planes seating 100 to 150 passengers.

The U.S. International Trade Commission (ITC) will now rule on whether Boeing was harmed by Bombardier’s sale. If not, the complaint and the tariff disappear unless Boeing appeals. If the ITC does conclude that the sale harmed Boeing, Bombardier’s CS-100 planes imported into the United States will be charged the duty fees. Bombardier will certainly appeal.

On Thursday Boeing signed a firm order with UAE-based flydubai airlines for 175 of the company’s 737 MAX jets. The airline committed to the order at the Dubai Air Show last month, but the firm order adds the planes to Boeing’s backlog.

Boeing also confirmed on Thursday that it has discussed a “possible combination” with Brazil’s Embraer S.A. (NYSE: ERJ), a response to the deal Bombardier struck with Airbus in which the European company took control of Bombardier’s C Series program. A deal between Boeing and Embraer is no sure thing, mainly because the Brazilian government holds a controlling interest in Embraer.

On Friday, Boeing announced that it has sold a KC-46 refueling tanker to Japan on fixed-price contract valued at $279 million. This could be a big deal because it is the first KC-46 Boeing has sold to a non-U.S. buyer.

The U.S. Air Force also awarded Boeing a contract to sell 36 F-15 fighter jets to Qatar in a deal worth $6.1 billion. The sale had originally been set at 72 aircraft with a contract value of more than $21 billion.

Boeing stock closed at $295.10 on Friday, up less than 0.1% on the day, in a 52-week trading range of $154.96 to $97.37. The high was posted Friday morning. The 12-month consensus price target is $299.33, down about $7.80 from last week’s target. The low price target is $203 and the high is $350.

24/7 Wall St.
General Electric Will Certainly Be 2017’s Worst DJIA Stock